FindTrial
Sign In

Artificial intelligence diagnosis of sentinel lymph node of breast cancer based on contrast-enhanced ultrasound

Artificial intelligence diagnosis of sentinel lymph node of breast cancer based on contrast-enhanced ultrasound

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031231
Enrollment
Unknown
Registered
2020-03-25
Start date
2020-04-30
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast

Interventions

Gold Standard:Pathology
Index test:Artificial&#32
intelligence&#32
diagnosis&#32
system&#32
based&#32
on&#32
contrast-enhanced&#32
ultrasound

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) aged >18 years; 2) patients with breast cancer confirmed by biopsy; Or bi-rdas 4c and above in patients with breast nodules 3) negative clinical diagnosis of axillary lymph nodes; 4) sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) contraindications of ultrasound contrast agent; 2) a history of axillary surgery for ipsilateral breast cancer; 3) no axillary surgery plan.

Design outcomes

Primary

MeasureTime frame
Contrast-enhanced ultrasound;Lymph node morphology;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactZhu Qingli

Beijing Union Medical College Hospital

zqlpumch@126.com+86 18810570355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026